PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma

NCT02705508 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Treatment Refusal

Interventions

DRUG: Gemcitabine
DRUG: etoposide
DRUG: Pegaspargase
RADIATION: involved-field radiotherapy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]